Body composition in long-term survivors of childhood acute lymphoblastic leukemia (ALL) [1]

Medical and Pediatric Oncology

Volumn 40, Issue 6, 2003, Pages 407-

  Van der Sluis, Inge M ^a   Van den Heuvel, Marry M ^a   De Muinck Keizer Schrama, Sabine M P F ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

ALL survivors; Body mass index; Lean body mass; Percentage body fat; X ray absorptiometry

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; DEXAMETHASONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; GROWTH DISORDER; HUMAN; LETTER; OBESITY; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; BODY COMPOSITION; BODY HEIGHT; CHILD; CRANIAL IRRADIATION; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; OBESITY; SURVIVORS;

EID: 0242500771     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10220     Document Type: Letter

References (5)

1. Warner JT, Evans WD, Webb DKB, et al. Body composition of long-term survivors of acute lymphoblastic leukaemia. Med Pediatr Oncol 2002;38:165-172.
2. Van Dongen-Melman JEWM, Hokken-Koelega ACS, Hählen K, et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995;38:86-90.
3. Van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000; 35:415-420.
4. Veerman AJP, Hählen K, Kamps WA, et al. High cure rate with moderate intensive treatment regimen in non-high risk childhood lymphoblastic leukemia: Results of protocol ALL VI from the Dutch Childhood leukemia study group. J Clin Oncol 1996;14:911-918.
5. Van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-210.